Showing results (91-100 of 110) with videos related to
Sort By:
Pageof 11
Breast Cancer Research and Treatment|September 16, 2005
Post-operative arm morbidity and quality of life. Results of the ALMANAC randomised trial comparing sentinel node biopsy with standard axillary treatment in the management of patients with early breast cancerAnne Fleissig, Lesley J Fallowfield, Carolyn I Langridge, et al.European Journal of Cancer (Oxford, England : 1990)|June 14, 2005
Tuberin and hamartin are aberrantly expressed and linked to clinical outcome in human breast cancer: the role of promoter methylation of TSC genesWen G Jiang, Julian Sampson, Tracey A Martin, et al.Breast (Edinburgh, Scotland)|March 30, 2019
Trends in axillary lymph node dissection for early-stage breast cancer in Europe: Impact of evidence on practiceCarlos A Garcia-Etienne, Robert E Mansel, Mariano Tomatis, et al.Lancet (London, England)|December 17, 2019
Use of anastrozole for breast cancer prevention (IBIS-II): long-term results of a randomised controlled trialJack Cuzick, Ivana Sestak, John F Forbes, et al.Journal of Women'S Health (2002)|December 14, 2017
A Randomized Controlled Multicenter Trial of an Investigational Liquid Nutritional Formula in Women with Cyclic Breast Pain Associated with Fibrocystic Breast ChangesRobert E Mansel, Tapas Das, Geraldine E Baggs, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 2, 2003
Reduction of stromal fibroblast-induced mammary tumor growth, by retroviral ribozyme transgenes to hepatocyte growth factor/scatter factor and its receptor, c-METWen G Jiang, David Grimshaw, Tracey A Martin, et al.Molecular Cancer|March 8, 2008
Lymphangiogenesis and lymph node metastasis in breast cancerGiles H Cunnick, Wen G Jiang, Tony Douglas-Jones, et al.Journal of Medicinal Food|September 24, 2004
Pomegranate extracts potently suppress proliferation, xenograft growth, and invasion of human prostate cancer cellsMartin Albrecht, Wenguo Jiang, James Kumi-Diaka, et al.Lancet (London, England)|December 17, 2013
Anastrozole for prevention of breast cancer in high-risk postmenopausal women (IBIS-II): an international, double-blind, randomised placebo-controlled trialJack Cuzick, Ivana Sestak, John F Forbes, et al.European Journal of Cancer (Oxford, England : 1990)|October 1, 2017
Quality indicators in breast cancer care: An update from the EUSOMA working groupLaura Biganzoli, Lorenza Marotti, Christopher D Hart, et al.Pageof 11